Abstract
Multivariate quantitative structure-activity relationship (QSAR) modeling, involving simultaneous modeling of activities towards several related endpoints, has emerged recently as an alternative to creating a group of separate models of each activity. The development of multivariate QSAR modeling has been driven by three factors. First, the number of aspects considered vital at earlier stages in the drug development pipeline has increased. Second, advanced screening technology has shifted the rate limiting step of drug discovery and development to other areas. Screening compounds for multiple properties has resulted in the availability of multi-endpoint datasets. Finally, the statistical and computational methods used in data analysis have evolved to allow for handling an increased complexity associated with multi-task prediction. In this review, we outline the justifications for the use of multivariate QSAR modeling. We review the techniques used for developing such models and their applications in drug discovery. We also summarize the methods for visual analysis of multivariate datasets. We focus on neural networks and other advanced, non-linear methods gaining popularity in the QSAR community, while also describing established linear techniques.
Keywords: QSAR, multivariate regression, multivariate analysis, neural networks
Current Computer-Aided Drug Design
Title: Multivariate Modeling and Analysis in Drug Discovery
Volume: 3 Issue: 4
Author(s): Tomasz Arodz and Arkadiusz Z. Dudek
Affiliation:
Keywords: QSAR, multivariate regression, multivariate analysis, neural networks
Abstract: Multivariate quantitative structure-activity relationship (QSAR) modeling, involving simultaneous modeling of activities towards several related endpoints, has emerged recently as an alternative to creating a group of separate models of each activity. The development of multivariate QSAR modeling has been driven by three factors. First, the number of aspects considered vital at earlier stages in the drug development pipeline has increased. Second, advanced screening technology has shifted the rate limiting step of drug discovery and development to other areas. Screening compounds for multiple properties has resulted in the availability of multi-endpoint datasets. Finally, the statistical and computational methods used in data analysis have evolved to allow for handling an increased complexity associated with multi-task prediction. In this review, we outline the justifications for the use of multivariate QSAR modeling. We review the techniques used for developing such models and their applications in drug discovery. We also summarize the methods for visual analysis of multivariate datasets. We focus on neural networks and other advanced, non-linear methods gaining popularity in the QSAR community, while also describing established linear techniques.
Export Options
About this article
Cite this article as:
Arodz Tomasz and Dudek Z. Arkadiusz, Multivariate Modeling and Analysis in Drug Discovery, Current Computer-Aided Drug Design 2007; 3 (4) . https://dx.doi.org/10.2174/157340907782799381
DOI https://dx.doi.org/10.2174/157340907782799381 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
Call for Papers in Thematic Issues
Artificial Intelligence in Biomedical Research: Enhancing Data Analysis for Drug Discovery and Development
This thematic issue highlights the transformative impact of Artificial Intelligence (AI), with a particular focus on Machine Learning (ML) and Deep Learning (DL) techniques, in advancing biomedical research. As a result of these cutting-edge AI methodologies, drug discovery and development are revolutionizing data analysis. Rapid advances in artificial intelligence technologies ...read more
Computational Design of Plant-Based Therapeutics
Plant-based therapeutics have a long history of use in traditional medicine and are gaining renewed interest due to their potential for treating various diseases, including cancer, diabetes, and neurodegenerative disorders. However, the traditional approach to plant-based drug discovery is often time-consuming and resource-intensive. Computational methods offer a powerful and efficient ...read more
Computer-Aided Drug Discoveries for Emerging Diseases
Computer-aided drug design is a rapidly growing research field that continues to gain momentum, attracting increasing interest from the scientific community. This trend is largely driven by the growing utilization of machine learning and artificial intelligence in drug design and discovery. Artificial Intelligence has proven efficacy across various applications, including ...read more
Deep Learning Approaches in Bioinformatics for Computer-Aided Drug Development Targeting Brain Tumors
The integration of deep learning and bioinformatics is revolutionizing the field of computer-aided drug development, particularly in the fight against brain tumors one of the most aggressive and lethal types of cancer. Brain tumors present significant challenges due to their heterogeneity and complexity, which require novel approaches for early diagnosis ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanostructures for Drug Delivery to the Brain
Current Medicinal Chemistry Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy The Psychopharmacology of Appetite: Targets for Potential Anti-Obesity Agents
Current Medicinal Chemistry - Central Nervous System Agents Devices for Umbilical Cord Blood Collection
Recent Patents on Engineering MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews QSAR in the Pharmaceutical Research Setting: QSAR Models for Broad, Large Problems
Current Topics in Medicinal Chemistry Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics
CNS & Neurological Disorders - Drug Targets Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after Lipopolysaccharide Stimulation through Targeting CXCR5
CNS & Neurological Disorders - Drug Targets <sup>89</sup>Zr-PET Radiochemistry in the Development and Application of Therapeutic Monoclonal Antibodies and Other Biologicals
Current Topics in Medicinal Chemistry Will Diverse Tat Interactions Lead to Novel Antiretroviral Drug Targets?
Current Drug Targets Chemistry and Pharmacological Properties of Some Natural and Synthetic Antioxidants for Heavy Metal Toxicity
Current Medicinal Chemistry Can we Target the Chemokine Network for Cancer Therapeutics?
Current Cancer Drug Targets Law-Medicine Interfacing: Patenting of Human Genes and Mutations
Recent Patents on DNA & Gene Sequences The Evidence for Automated Grading in Diabetic Retinopathy Screening
Current Diabetes Reviews High Order Texture-Based Analysis in Biomedical Images
Current Medical Imaging Etiological and Biological Aspects of Cigarette Smoking in Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Red Wine, Arterial Stiffness and Central Hemodynamics
Current Pharmaceutical Design A Pictorial Review of Intracranial Haemorrhage Revisited
Current Medical Imaging Synthesis, Structure Elucidation and Biological Activities of Some Novel 4(3H)-Quinazolinones as Anti-Biofilm Agents
Letters in Drug Design & Discovery Case Report of Sotalol Induced IgA Vasculitis
Current Rheumatology Reviews